Nektar Therapeutics (NKTR) Interest Coverage Ratio Growth (3y) (2013 - 2020)
Nektar Therapeutics (NKTR) Interest Coverage Ratio Growth (3y) (2013 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nektar Therapeutics |
1.51 Bn |
939.55 Mn |
3.16 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2020 |
-135.52% |
| Mar 31, 2020 |
-28.81% |
| Dec 31, 2019 |
-51.65% |
| Sep 30, 2019 |
-45.90% |
| Jun 30, 2019 |
-46.04% |
| Mar 31, 2019 |
-140.00% |
| Dec 31, 2018 |
-54.01% |
| Sep 30, 2018 |
-468.53% |
| Jun 30, 2018 |
167.44% |
| Mar 31, 2018 |
-52.89% |
| Dec 31, 2017 |
20.25% |
| Sep 30, 2017 |
-11.82% |
| Jun 30, 2017 |
-21.66% |
| Mar 31, 2017 |
-7.86% |
| Dec 31, 2016 |
9.69% |
| Sep 30, 2016 |
-60.31% |
| Jun 30, 2016 |
0.92% |
| Mar 31, 2016 |
44.38% |
| Dec 31, 2015 |
18.20% |
| Sep 30, 2015 |
26.35% |
